Neovasc Inc Quick Ratio (NVCN) starting from the fourth quarter 2021 to fourth quarter 2020, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Neovasc Inc   (NASDAQ: NVCN)

Neovasc Inc 's Quick Ratio

NVCN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Neovasc Inc 's Cash & cash equivalent grew by 1.04 % in the Q4 2021 sequentially, while Current Liabilities decreased, this led to improvement in Neovasc Inc 's Quick Ratio to 10.45, above Neovasc Inc average Quick Ratio.

Within Medical Equipment & Supplies industry 28 other companies have achieved higher Quick Ratio than Neovasc Inc in fourth quarter 2021. While Quick Ratio total ranking has improved so far during the Q4 2021 to 620, from total ranking in the third quarter 2021 at 623.

Explain Quick Ratio?
How much Cash & cash equivalents NVCN´s has?
What are NVCN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVCN Quick Ratio (Dec 31 2021)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2020)
Q4
Y / Y Current Liabilities Change - -66.16 % -66.16 % -66.16 % -
Y / Y Cash & cash equivalent Change 286.2 % 873.72 % 873.72 % 873.72 % 154.76 %
Quick Ratio MRQ 10.45 10.35 10.35 10.35 -
NVCN's Total Ranking # 620 # 623 # 623 # 623 #
Seq. Current Liabilities Change 0 % 0 % 0 % - -
Seq. Cash & cash equivalent Change 1.04 % 0 % 0 % 282.22 % 154.76 %



Quick Ratio fourth quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 29
Healthcare Sector # 315
Overall Market # 620


Quick Ratio Statistics
High Average Low
10.35 3.94 0.36
(Dec 31 2021)   (Dec 31 2019)




Financial Statements
Neovasc Inc 's Current Liabilities $ 5 Millions Visit NVCN's Balance sheet
Neovasc Inc 's Cash & cash equivalent $ 52 Millions Visit NVCN's Balance sheet
Source of NVCN's Sales Visit NVCN's Sales by Geography


Cumulative Neovasc Inc 's Quick Ratio

NVCN's Quick Ratio for the trailling 12 Months

NVCN Quick Ratio

 (Dec 31 2021)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2020)
12 Months
Y / Y Current Liabilities TTM Growth -54.88 % -74.62 % -52.93 % -25.16 % 11.67 %
Y / Y Cash & cash equivalent TTM Growth 603.92 % 693.98 % 385.05 % 160.07 % -11.08 %
Quick Ratio TTM 10.37 11.25 4.94 2.2 0.66
Total Ranking TTM # 4969 # 5645 # 5718 # 5715 #
Seq. Current Liabilities TTM Growth 33.33 % -39.46 % -28.29 % -22.05 % -25 %
Seq. Cash & cash equivalent TTM Growth 22.96 % 37.95 % 61.16 % 157.5 % 38.69 %

Quick ratio ranking by company, industry and sector >> Back to NVCN Financial Strength Comparisons >> Go to Compare NVCN Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q4 2021 to $4.98 millions, cumulative Quick Ratio decreased to 10.37 above the NVCN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 223 other companies have achieved higher Quick Ratio than Neovasc Inc . While Quick Ratio overall ranking has improved so far to 4969, from total ranking during the twelve months ending third quarter 2021 at 5645.

Explain Quick Ratio?
How much Cash & cash equivalents NVCN´s has?
What are NVCN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 224
Healthcare Sector # 1147
Within the Market # 4969


trailing twelve months Quick Ratio Statistics
High Average Low
10.35 2.81 0.36
(Dec 31 2021)   (Dec 31 2019)




Companies with similar Quick Ratio in the quarter ending Dec 31 2021, within Medical Equipment & Supplies Industry Quick RatioDec 31 2021 MRQ Cash & cash equivalentDec 31 2021 MRQ Current Liabilities
Valion Bio Inc   24.32 $ 25.775  Millions$ 1.060  Millions
Heartbeam Inc   22.44 $ 13.192  Millions$ 0.588  Millions
Femasys Inc   19.57 $ 24.783  Millions$ 1.266  Millions
Sight Sciences Inc   19.30 $ 260.687  Millions$ 13.504  Millions
Cvrx inc   18.11 $ 142.072  Millions$ 7.847  Millions
Novocure Limited  17.11 $ 1,242.504  Millions$ 72.600  Millions
Procept Biorobotics Corporation  16.76 $ 304.320  Millions$ 18.159  Millions
Neurometrix Inc   16.53 $ 22.572  Millions$ 1.366  Millions
Utah Medical Products Inc  16.28 $ 60.974  Millions$ 3.745  Millions
Collplant Biotechnologies Ltd  16.15 $ 43.312  Millions$ 2.682  Millions
Talkspace Inc   15.70 $ 198.256  Millions$ 12.629  Millions
Sanara Medtech Inc   14.55 $ 21.487  Millions$ 1.476  Millions
Neuropace Inc   12.43 $ 115.584  Millions$ 9.301  Millions
Avita Medical Inc   12.22 $ 85.284  Millions$ 6.978  Millions
Sonendo Inc   11.82 $ 84.641  Millions$ 7.163  Millions
Nyxoah Sa  11.71 $ 153.369  Millions$ 13.097  Millions
Clearpoint Neuro Inc   11.38 $ 54.109  Millions$ 4.753  Millions
Asensus Surgical Inc   11.12 $ 98.391  Millions$ 8.848  Millions
Orchestra Biomed Holdings Inc   10.60 $ 1.754  Millions$ 0.166  Millions
Neovasc Inc   10.45 $ 52.075  Millions$ 4.982  Millions
Microbot Medical Inc   10.30 $ 17.578  Millions$ 1.706  Millions
Catheter Precision Inc   10.26 $ 15.045  Millions$ 1.466  Millions
Pavmed Inc   10.22 $ 77.258  Millions$ 7.558  Millions
Inspire Medical Systems inc   10.06 $ 214.467  Millions$ 21.321  Millions
Vivos Inc  9.62 $ 1.606  Millions$ 0.167  Millions
Milestone Scientific Inc   9.55 $ 29.564  Millions$ 3.097  Millions
Inmode Ltd   9.46 $ 417.627  Millions$ 44.124  Millions
Si bone inc   9.45 $ 146.979  Millions$ 15.551  Millions
Semler Scientific inc   9.43 $ 37.323  Millions$ 3.959  Millions
Achari Ventures Holdings Corp I  9.12 $ 0.771  Millions$ 0.085  Millions

Date modified: 2023-03-24T17:08:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.